Ondansetron Tablet, Orally Disintegrating
Product Images NDC 70518-3512

11 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 70518-3512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure-hcl (Structure HCl)

Structure-hcl (Structure HCl)
Chemical structure of Ondansetron hydrochloride dihydrate is shown, depicting its molecular arrangement including benzene rings, nitrogen atoms, a ketone group, methyl groups, and dihydrate with hydrochloride salt.*
FDA Label Image

Structure-base (Structure Base)

Structure-base (Structure Base)
Chemical structure of ondansetron, showing its molecular framework including fused rings and functional groups consistent with the active ingredient of Ondansetron orally disintegrating tablets.*
FDA Label Image

Mm1 (Ondansetron 4mg 70518 3512 00)

Mm1 (Ondansetron 4mg 70518 3512 00)
Ondansetron 4 mg Orally Disintegrating Tablets packaging label shows a quantity of 30 tablets. The label includes the NDC number 70518-3512-00, states the tablets are round, white, and marked with G;4. The labeler is RemedyRepack Inc. The label warns of phenylalanine content and provides storage instructions, including recommended temperatures and a caution to keep out of reach of children. Manufacturer information for Glenmark in Mahwah, NJ is also present.*
FDA Label Image

Mm2 (Ondansetron 4mg 70518 3512 01)

Mm2 (Ondansetron 4mg 70518 3512 01)
Ondansetron 4 mg orally disintegrating tablets packaging label. It shows a quantity of 6 tablets with NDC 70518-3512-01. The label indicates the product is repackaged by RemedyRepack Inc., Indiana, PA, and includes storage instructions and a note about phenylketonurics. Manufacturer Glenmark, Mahwah, NJ, is also mentioned.*
FDA Label Image

Mm3 (Ondansetron 4mg 70518 3512 02)

Mm3 (Ondansetron 4mg 70518 3512 02)
Ondansetron 4 mg orally disintegrating tablets packaging label. The label indicates a quantity of 10 tablets and includes the NDC number 70518-3512-02. It states the product is repackaged by RemedyRepack Inc., located in Indiana, PA, and includes storage instructions along with manufacturer details (Glenmark, Mahwah, NJ). The label also contains a warning for phenylketonurics.*
FDA Label Image

Mm4 (Ondansetron 4mg 70518 3512 03)

Mm4 (Ondansetron 4mg 70518 3512 03)
Ondansetron Tablet 4 mg orally disintegrating, labeled for a quantity of 20 tablets. The label indicates the product is repackaged by Remedy Repack Inc., Indiana, PA. It includes storage instructions, phenylketonurics warning for phenylalanine, and manufacturer details for Glenmark, Mahwah, NJ. The NDC is 70518-3512-03.*
FDA Label Image

Mm5 (Ondansetron 4mg 70518 3512 04)

Mm5 (Ondansetron 4mg 70518 3512 04)
Ondansetron 4 mg orally disintegrating tablets packaging label showing 12 tablets per bottle by RemedyRepack Inc. The label includes the product name, strength, quantity, NDC number 70518-3512-04, storage instructions, and a note about phenylalanine content for phenylketonurics. Manufacturer details and a QR code are also present.*
FDA Label Image

Mm6 (Ondansetron 4mg 70518 3512 05)

Mm6 (Ondansetron 4mg 70518 3512 05)
Ondansetron 4 mg orally disintegrating tablets packaging label showing a quantity of 9 tablets. The label lists the NDC number 70518-3512-05 and states the product is repackaged by RemedyRepack Inc., Indiana, PA. It includes storage instructions, a warning for phenylketonurics about phenylalanine content, and notes the manufacturer as Glenmark, Mahwah, NJ.*
FDA Label Image

Mm7 (Ondansetron 4mg 70518 3512 06)

Mm7 (Ondansetron 4mg 70518 3512 06)
Ondansetron 4 mg orally disintegrating tablets. The label indicates a quantity of 21 tablets per package. The product is repackaged by RemedyRepack Inc., located in Indiana, PA. The label also includes storage instructions and a warning about phenylalanine content. The manufacturer listed is Glenmark, Mahwah, NJ.*
FDA Label Image

Mm8 (Ondansetron 4mg 70518 3512 07)

Mm8 (Ondansetron 4mg 70518 3512 07)
Ondansetron 4 mg orally disintegrating tablet packaging label showing quantity of 15 tablets. The label indicates the product is round, white, and marked with G;4. It includes storage instructions, manufacturer details Glenmark, and repackager RemedyRepack Inc. with contact information and NDC 70518-3512-07. The label mentions phenylalanine content and advises to keep medication out of children's reach.*
FDA Label Image

Mm9 (Ondansetron 4mg 70518 3512 08)

Mm9 (Ondansetron 4mg 70518 3512 08)
Ondansetron 4 mg Orally Disintegrating Tablet label showing quantity of 3 tablets. Label includes manufacturer information, storage instructions, and a warning for phenylketonurics regarding phenylalanine content. Repackaged by RemedyRepack Inc., Indiana, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.